Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter De Cruz

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Journal of Gastroenterology and Hepatology|September 7, 2018
Risk stratifying in real lifePeter De Cruz
Journal of Gastroenterology and Hepatology|March 19, 2016
New models of care in IBD in changing timesPeter De Cruz
Expert Review of Gastroenterology & Hepatology|October 5, 2018
Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitisBelinda Jackson, Peter De Cruz
JMIR Mhealth and Uhealth|February 3, 2016
Mobile Phone Apps for Inflammatory Bowel Disease Self-Management: A Systematic Assessment of Content and ToolsDanny Con, Peter De Cruz
Scandinavian Journal of Gastroenterology|June 8, 2017
Review article: a practical approach to the clinical management of NSAID enteropathyAshish Srinivasan, Peter De Cruz
Intestinal Research|May 7, 2024
Defining management strategies for acute severe ulcerative colitis using predictive models: a simulation-modeling studyDanny Con, Peter De Cruz
Evidence-Based Medicine|February 3, 2009
Practice corner: should we screen all patients starting chemotherapy for chronic hepatitis B virus infection?Sue-Anne McLachlan, Peter De Cruz
Gastroenterology|May 5, 2015
Reply: To PMID 25542620Peter De Cruz, Michael A Kamm
Inflammatory Bowel Diseases|September 1, 2018
Quality of Care in Patients With Inflammatory Bowel DiseaseBelinda D Jackson, Peter De Cruz
Journal of Crohn'S & Colitis|April 2, 2020
Ustekinumab is a Safe and Effective Biological Agent for Crohn's Disease in a Liver Transplant PatientMatthew Peverelle, Khashayar Asadi, Peter De Cruz
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Journal of Gastroenterology and Hepatology|September 7, 2018
Risk stratifying in real lifePeter De Cruz
Journal of Gastroenterology and Hepatology|March 19, 2016
New models of care in IBD in changing timesPeter De Cruz
Expert Review of Gastroenterology & Hepatology|October 5, 2018
Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitisBelinda Jackson, Peter De Cruz
JMIR Mhealth and Uhealth|February 3, 2016
Mobile Phone Apps for Inflammatory Bowel Disease Self-Management: A Systematic Assessment of Content and ToolsDanny Con, Peter De Cruz
Scandinavian Journal of Gastroenterology|June 8, 2017
Review article: a practical approach to the clinical management of NSAID enteropathyAshish Srinivasan, Peter De Cruz
Intestinal Research|May 7, 2024
Defining management strategies for acute severe ulcerative colitis using predictive models: a simulation-modeling studyDanny Con, Peter De Cruz
Evidence-Based Medicine|February 3, 2009
Practice corner: should we screen all patients starting chemotherapy for chronic hepatitis B virus infection?Sue-Anne McLachlan, Peter De Cruz
Gastroenterology|May 5, 2015
Reply: To PMID 25542620Peter De Cruz, Michael A Kamm
Inflammatory Bowel Diseases|September 1, 2018
Quality of Care in Patients With Inflammatory Bowel DiseaseBelinda D Jackson, Peter De Cruz
Journal of Crohn'S & Colitis|April 2, 2020
Ustekinumab is a Safe and Effective Biological Agent for Crohn's Disease in a Liver Transplant PatientMatthew Peverelle, Khashayar Asadi, Peter De Cruz
Pageof 13